| 000 | 01782 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516015913.0 | ||
| 264 | 0 | _c20120330 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1435-1463 | ||
| 024 | 7 |
_a10.1007/s00702-010-0552-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrünblatt, E | |
| 245 | 0 | 0 |
_aTranscriptional alterations under continuous or pulsatile dopaminergic treatment in dyskinetic rats. _h[electronic resource] |
| 260 |
_bJournal of neural transmission (Vienna, Austria : 1996) _cDec 2011 |
||
| 300 |
_a1717-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xpathology |
| 650 | 0 | 4 | _aFunctional Laterality |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aLevodopa _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
| 650 | 0 | 4 |
_aNeurotrophin 3 _xgenetics |
| 650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xchemically induced |
| 650 | 0 | 4 | _aPulsatile Flow |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aSchmidt, W J | |
| 700 | 1 | _aScheller, D K A | |
| 700 | 1 | _aRiederer, P | |
| 700 | 1 | _aGerlach, M | |
| 773 | 0 |
_tJournal of neural transmission (Vienna, Austria : 1996) _gvol. 118 _gno. 12 _gp. 1717-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00702-010-0552-y _zAvailable from publisher's website |
| 999 |
_c20475476 _d20475476 |
||